ArticleJournal for immunotherapy of cancer2020

Antitumor efficacy of combined CTLA4/PD-1 blockade without intestinal inflammation is achieved by elimination of FcγR interactions.

David Bauché et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.